Vivatuxin®, a chimeric tumor necrosis therapy approved by China’s State Food and Drug Administration for lung cancer . If we go this way it imo will have to get approve by US food an drug administration.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.